Restrictive eligibility limits access to newer therapies in non-small-cell lung cancer: the implications of Eastern Cooperative Oncology Group 4599

Title : Restrictive eligibility limits access to newer therapies in non-small-cell lung cancer: the implications of Eastern Cooperative Oncology Group 4599

Source : PubMed
ID : 18501096
Authors : Somer RA, Sherman E, Langer CJ
Year : 2008
Disease Category : Cancer
Focused Population : Not Specified
Priori/Posteriori : Priori
Single-study Generalibility? : Single
Score/Non-Score : Non-score
Tutorial/Method : Determine the proportion of patients with newly evaluated advanced NSCLC seen at Fox Chase Cancer Center (FCCC) who would have been eligible for ECOG 4599
Compared general demographic and patient characteristics : No
Compared disease-specific clinical characteristics : No
Compared adverse events : No
Compared outcomes/treatment effect (including survival) : No
Real-world data sources : trial participant / those who would be eligible
Target Population Data Type Levels : Trial
Descriptive Statistics : Yes

Welcome to the College of Communication & Information

Schools and Colleges

Centers of Distinction

CTGATE: Clinical Trial Generalizability Assessment Toolbox

Clinical Trial Generalizability Assessment Informatics Toolbox

Title : Restrictive eligibility limits access to newer therapies in non-small-cell lung cancer: the implications of Eastern Cooperative Oncology Group 4599